Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins
Open Access
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Lipid Research
- Vol. 44 (5) , 927-934
- https://doi.org/10.1194/jlr.m200452-jlr200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Peroxisome proliferator-activated receptor-α activation and high-density lipoprotein metabolismThe American Journal of Cardiology, 2001
- Ppars, metabolic disease and atherosclerosisPharmacological Research, 2001
- Oxidized LDL and HDL: antagonists in atherothrombosisThe FASEB Journal, 2001
- Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoproteinBiochemical Journal, 2001
- Hydrolysis of platelet-activating factor by human serum paraoxonaseBiochemical Journal, 2001
- Apolipoprotein B-100 Conformation and Particle Surface Charge in Human LDL Subspecies: Implication for LDL Receptor InteractionBiochemistry, 1998
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteinsCurrent Opinion in Lipidology, 1996
- Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic TriadJournal of Biological Chemistry, 1995
- PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseNature, 1995